Ava AG

Boltendahl International Partners organizes a private placement in the CHF 30m Series B Round for Ava AG.

Ava is a medical technology company focused on innovations in women’s reproductive health and maker of the popular cycle tracking Ava bracelet. Ava, being a digital diagnostics and therapeutics company has the vision to provide data-driven and scientifically proven insights along all stages of a woman’s reproductive life.

Ava’s long-term vision is to accompany women through all stages of their reproductive life by providing data-driven, clinically proven technology that will make a woman’s life easier, healthier and better -- be it when they just want to understand their body, while they are trying to prevent pregnancy, trying to get pregnant, are pregnant or entering menopause Ava's CEO Koenig

Juan Capurro Boltendahl

Become a member

Join us